课题基金 / 基金详情

Role of leukotriene receptor antagonists in the treatment and prevention of dementia and cardiovascular disease: a longitudinal study using Ontario health administrative data

Role of leukotriene receptor antagonists in the treatment and prevention of dementia and cardiovascular disease: a longitudinal study using Ontario health administrative data
白三烯受体拮抗剂在治疗和预防痴呆和心血管疾病中的作用：使用安大略省卫生行政数据的纵向研究
批准号：
458258
负责人：
Xiong Lisa
金额：
$7.65万
依托单位：
Sunnybrook Research Institute (Toronto, Ontario)
依托单位国家：
加拿大
项目类别：
Studentship Programs
财政年份：
2021
资助国家：
加拿大
项目状态：
已结题
起止时间：
2021-11-01 至 2024-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=458258&lang=en
关键词：
Alzheimer'S Disease Cardiovascular Disease Cohort Dementia Leukotriene Receptor Antagonists Longitudinal Pharmacoepidemiology Propensity Score Matching

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Alzheimer's disease (AD) and cardiovascular disease (CVD) affect many elderly people and are among the top 10 leading causes of death among Canadians. AD affects the brain and causes dementia, a condition characterized by a progressive decline in a person
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金